|
-
Yom Kippur is Monday, September 25, 2023. While the college central offices will observe the holiday, the OGS staff will be available. Reach out to the Einstein-OGS team at OGS@einsteinmed.edu for assistance.
-
All proposals (both federal and non-federal, including limited sub-missions and private foundations) must get approved by OGS first in Cayuse before it goes for final submission to the funding agencies.
-
Select Dr. Indranil Basu as SO, BO or AOR as you find on the drop-down menu of the grant application portals. For DOD proposals, select Dr. Basu's name on both #5 and #19 in Cayuse 424.
-
We strongly recommend submitting the applications to funding agencies at least 24 - 48 hours before the deadline date and time.
| |  |
-
Einstein policy# GRT-POL-2018-001 Section III.B.3 outlines that the Cayuse administrative forms and budget are due to the OGS 8 business day routing before the deadline of the sponsor due date.
-
Please note that Latesha Paisley and Linda Lally from the RF Award set-up have begun reviewing proposal budgets. They will review all proposals and non-NIH RPPRs budget details. Gerard McMorrow will resume responsibility for all the clinical departments. Latesha and Linda will keep the basic science departments. This structure will remain through the October 5th deadline.
-
For eRA Commons user ID setup and verification, contact Cynthia Cardillo.
-
For JIT, FIS, NCE, Carryover and any help with ASSIST, contact Bethany Oates.
-
Melanie Bourghol manages the application review in Cayuse SP and 424.
-
DMS Plan review requests may be made to Dr. Indranil Basu at least 3 days before the grant deadline. Make sure to address all 6 elements without any URLs or hyperlinks. The NIH and DOD DMS plan templates are available on request.
| |
Important links, forms and documents | |
NIH Fundamentals Workshop Handout by NCURA
Please click here for the slides of NIH Fundamentals Live Virtual Workshop hosted by NCURA on August 9th, 2023.
| |
Please click here for the OGS DA roundtable meeting slides from 09/05/23. | |
Please click here to find out how to submit a Reference Letter for an applicant.
| |
|
Institutional Giving - Montefiore Einstein
Institutional Giving is part of the Office of Development and Alumni Affairs. The team members are - Pamela Heller, Assistant Vice President, Audrey McInerney, Senior Director, Caitlin Young, Associate Director, and Karen Awunyo, Senior Development Associate. They are involved in the following activities -
1) Raising funds from private foundations, public charities, and corporations to support research, medical education, and patient care programs at Montefiore Einstein.
2) Fostering strong, long-term relationships with institutional donors with the goal of increasing giving, and identifying new donors with missions that align with Montefiore Einstein's priorities.
3) Pre-proposal, they research potential funders, track proposal deadlines, communicate with foundation staff, publicize RFPs, and identify applicants.
4) Assisting PIs with proposal preparation and submission by providing institutional information, reviewing and editing narrative text, inputting information into application portals, and fielding questions for the funders.
5) Managing site visits and events, tracking stewardship report deadlines, and helping coordinate the submission of financial and narrative reports.
They can be reached at institutionalgiving@montefiore.org.
The list of Non-Governmental Funding Opportunities from the Office of Development’s Institutional Giving Team can be found here.
The link to the document in shared Box folder is here.
| | |
NOT-OD-23-161: NIH Application Instruction Updates Data Management and Sharing (DMS) Costs | |
Effective for applications submitted for due dates on or after October 5, 2023, NIH will require applicants to specify estimated "DMS cost" details within the “Budget Justification” attachment of the R&R Budget Form or “Additional Narrative Justification” attachment of the PHS398 Modular Budget Form, pursuant to the instructions.
While the single cost line item is no longer required, "DMS costs" must be requested in the appropriate cost category, e.g. personnel, equipment, supplies, and other expenses, following the instructions for the R&R Budget Form or PHS 398 Modular Budget Form, as applicable. The link to the NIH announcement dated July 31, 2023 can be found here.
| | | |
NOT-OD-23-133: NIH Updated Policy Guidance for Subaward/ Consortium Written Agreements | This notice updates Section 15.2 of the NIH Grants Policy Statement (NIHGPS), which describes the specifications for consortium/subaward agreements on NIH-funded grants. This updated guidance will be effective from October 1, 2023. These updates will be incorporated into the GPS in the FY24 publication. A Federal Register Notice announcing the updates will be posted in the upcoming weeks. | | | |
National Institutes of Health | Division of Loan Repayment | The NIH Extramural Loan Repayment Program (LRP) application cycle is open from September 1 to November 16 this year. Participants in the NIH LRPs can receive up to $100,000 of qualified educational debt repayment with a two-year award. Please contact lrp@nih.gov for further details. | | |
Funding Opportunities - Department of Defense, Congressionally Directed Medical Research Programs: Transforming Health Care through Innovative and Impactful Research
| Please click read more to find the open funding opportunities. | | | |
NSF Graduate Research Fellowship Program (GRFP) |
The program recognizes and supports outstanding graduate students who are pursuing full-time research-based master's and doctoral degrees in science, technology, engineering, and mathematics (STEM) or in STEM education. The GRFP provides three years of support over a five-year fellowship period for the graduate education of individuals who have demonstrated their potential for significant research achievements in STEM or STEM education.
Application Deadline(s) (received by 5 p.m. local time of applicant’s mailing address): October 16, 2023 (Life Sciences), October 17, 2023 (Computer and Information Science and Engineering, Materials Research, Psychology, Social Sciences, STEM Education and Learning). Please carefully review eligibility requirements and relevant scientific areas.
| | | |
Non-Federal Funding Opportunities | |
Open Call | 2024 Allen Discovery Center for Neurobiology in Changing Environments | |
Deepening our understanding of nervous systems in rapidly changing environments
ADC is excited to announce a 2024 Allen Discovery Center (ADC) initiative to support research that will elucidate the molecular, cellular and/or circuitry-level neurobiology governing fundamental biological processes (development, reproduction, etc.) in response to anthropogenic-driven environmental perturbation. Up to one award will be made for up to $10 million in total funding support provided over four years.
Letter of Intent (LOI) is due by noon Pacific Time September 20, 2023. Please contact Audrey McInerney (amcinerney@montefiore.org) for further details.
Open Call | 2024 ADC - Allen Institute
| | |
Apply to the LLS Discovery Grant Program (DGP) | |
The Leukemia & Lymphoma Society (LLS) is pleased to announce the opening of the Discovery Grant Program (DGP) for 2023-2024. DGP is a research award program designed to encourage basic research, technological innovation, and informatics pipeline development. The LOI is due on September 29, 2023, 3 PM (EST). The guidelines and instructions can be found here.
The Discovery Grant Program (DGP) is aimed at supporting cutting edge, innovative research that is discovery oriented, concerned with understanding blood cancer properties and vulnerabilities and aimed toward advancing treatments for blood cancers.
Examples of projects of potential interest include:
· cellular activities that underlie the behavior and vulnerabilities of blood cancer cells including phenomena or processes such as clonal evolution, autophagy, unique metabolic vulnerabilities, inflammation/inflammasomes, DNA damage responses, organellar changes, and poorly understood cellular regulatory mechanisms
· resistance mechanisms including immune evasion, resistant clone evolution and cellular changes underlying development of resistance to chemotherapies
· novel biomarkers or techniques to detect and monitor blood cancer development and progression
· blood cancer cell interactions with the microenvironment and with the immune system, including exploration of novel immune synapses
A detailed description of the LLS Discovery Grant Program and application instructions are available on the LLS Research Portal. All applications are to be submitted online through the LLS Research Portal. Applicants with research proposals that are responsive to the RFP should indicate this on the title page of their Full Proposal. LLS seeks proposals responsive to the above requests for proposals but will also consider other exceptional proposals with the near-term potential of clinical translation.
For additional questions regarding LLS research grant programs, eligibility, and application processes, please contact researchprograms@lls.org.
| | | |
Grant Opportunities - Alpha-1 Foundation | |
LOI Deadline: September 29
Amount: Up to $100,000 per year for up to two years
About: The Alpha-1 Foundation Grant Awards Program funds a wide range of meritorious research efforts designed to improve the health of individuals with AAT Deficiency with the goal of finding a cure.
- Bridge $25k/1 year Support excellent AAT-related research projects submitted to and approved the NIH unsupported by available NIH funds.
- Career Development $100k/3 years Facilitate the establishment of a career in biomedical research for junior physician-scientists working in AATD.
- Postdoctoral Fellowship $75k/2 years Support postdocs in labs of established researchers or those conducting research under AATD senior researchers.
- Pilot & Feasibility $75k/1 year Encourage the development/testing of new hypotheses/new methods in AATD relevant research.
- Research up to $100k/2 years Encourage the development of novel concepts to better understand the basic biology of alpha-1 antitrypsin expression and the pathogenesis/management of AAT Deficiency.
Link: Alpha 1 Grants
Contact: Audrey McInerney (amcineney@montefiore.org) for further information or assistance.
| | | |
The Mike Slive Foundation for Prostate Cancer Research has opened its 2023-2024 cycle for funding pilot grants focused on cutting-edge prostate cancer research. The foundation strives to become a global leader in the fight to eradicate prostate cancer through raising public awareness of early detection and funding research to end prostate cancer. The submission guidelines are attached and can also be found on the website under Proposal Guidelines. Applications are due by October 2, 2023 to the online submission portal. To see the past work we have funded, please visit our website. Please reach out to Emily Capilouto at emily@mikeslivefoundation.org with any questions. | | | |
Apply for Research Grant - Cystinosis Research Foundation | |
The Cystinosis Research Foundation is accepting applications for research studies and for the Post-Doctoral Cystinosis Research Fellowship Program. Our goal is to fund the best and most promising research in the world in an effort to find better treatments and a cure for cystinosis. CRF supports laboratory research, clinical and translational research aimed at understanding the pathogenesis of cystinosis as well as specific areas of cystinosis research that remain under-studied (e.g., neurological complications, endocrine complications, myopathy, hypogonadism, bone disease). The foundation is interested in supporting new investigators and encouraging them to apply either as research fellows or co-PIs. The CRF Grant Proposal, Fellowship Guidelines, and a cover sheet for research proposals and one for research fellowships can be found here. The cover sheets are mandatory for all applications submitted. The documents can also be found on the CRF website: https://www.cystinosisresearch.org/apply-for-research-grant/
To learn more about the foundation, visit our web site at https://www.cystinosisresearch.org/ or if you have any questions, please email Nancy Stack at nstack@cystinosisresearch.org.
The deadline for the Fall 2023 applications is Wednesday, October 4, 2023. All applicants will be notified about the status of their application in December, 2023.
| | | |
Career Awards for Medical Scientists - Burroughs Wellcome Fund | |
Deadline: October 17, 2023
Amount: $700k/5 years
About: This award is for physician-scientists who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service. Proposals must be in basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 12 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience. Proposals that incorporate artificial intelligence and machine learning or climate change and human health are of particular interest.
Eligibility: Candidates must hold an MD, DO, DVM, VMD, or DDS; have completed clinical training (residency or fellowship) and be board eligible by award start date; may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.); must be citizen or non-citizen permanent and temporary US resident legally qualified to work in the US. Additional requirements in the link below.
Links: BWF CAMS 2024 RFP and FAQs
Contact: Audrey McInerney (amcinerney@montefiore.org) for more information and/or assistance.
| | | |
Apply to the Academic Clinical Trials Program | |
The Leukemia & Lymphoma Society (LLS) is pleased to announce the opening of the Academic Clinical Trials Program for 2023-2024.
The LLS ACT initiative is a clinical trial award program designed to develop cutting edge treatments that will have a meaningful impact on blood cancer patients. These awards will fund clinical trials, up to $1M USD over a period of up to three years. The LOI is due on October 25, 2023, 3 PM (EST). The ACT program guidelines and instructions can be found here.
LLS is seeking truly novel advances. The LLS ACT initiative is designed to develop experimental agents to address unmet medical needs, expand the use of approved therapeutics, and improve the use of novel treatment regimens in clinical settings.
Projects addressing follicular lymphoma may be selected for co-funding. This funding will be provided in a collaborative partnership between LLS and the Follicular Lymphoma Foundation. Please see the Cure FL Appendix in the ACT guidelines and instructions, which can be located at the lls.org link below.
A detailed description of the LLS Academic Clinical Trials Program and application instructions are available on the LLS Research Portal or https://www.lls.org/academic-clinical-trials-program-act. All applications are to be submitted online through the LLS Research Portal.
For additional questions regarding LLS research grant programs, eligibility, and application processes, please contact researchprograms@lls.org.
| | | |
National Glaucoma Research Request for Proposals | |
New grants are available for research that begins in 2024, with an application deadline of October 31, 2023. BrightFocus provides research funds for U.S. domestic as well as international researchers to cover a wide range of investigator-initiated topics to better understand, treat, and prevent glaucoma, a leading cause of blindness. Please note that applicants to the NGR standard award program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines.
Postdoctoral Fellowship (maximum award value $150,000, 2 years)
Standard Award (maximum award value $200,000, up to 2 years)
Visit https://www.brightfocus.org/NGR-RFP for more information about the BrightFocus glaucoma grants, including how to apply.
| | | | | | |
